Feb 13 (Reuters)-
D.Western Therapeutics Institute Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2025 Dec 31, 2024 Dec 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 387 mln 469 mln 300 mln
(-17.5 pct) (+9.8 pct) (-22.6 pct)
Operating loss 566 mln loss 1.17
Recurring loss 571 mln loss 1.18 loss 760 mln
Net loss 622 mln loss 1.34 loss 760 mln
EPS loss 12.99 yen loss 38.15 yen loss 14.01 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T